2018
DOI: 10.1016/j.ccell.2018.07.002
|View full text |Cite
|
Sign up to set email alerts
|

Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes

Abstract: The molecular foundations of Hürthle cell carcinoma (HCC) are poorly understood. Here we describe a comprehensive genomic characterization of 56 primary HCC tumors that span the spectrum of tumor behavior. We elucidate the mutational profile and driver mutations and show that these tumors exhibit a wide range of recurrent mutations. Notably, we report a high number of disruptive mutations to both protein-coding and tRNA-encoding regions of the mitochondrial genome. We reveal unique chromosomal landscapes that … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

16
253
1
2

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
1

Relationship

3
3

Authors

Journals

citations
Cited by 202 publications
(272 citation statements)
references
References 69 publications
(90 reference statements)
16
253
1
2
Order By: Relevance
“…PAX8/PPARG rearrangements occur in approximately 8% of FA, 10% of NIFTP, 1% of follicular variant PTC and 20–30% of FTC. EIF1AX mutation can be found in hyperplastic nodules, FA, NIFTP, FTC, PTC, PDC, ATC and Hürthle cell carcinomas . Cytogenetic changes occur in 50% of FA and 65% of FTC .…”
Section: Genetic Profiles and Molecular Diagnosis Of Thyroid Tumorsmentioning
confidence: 99%
See 4 more Smart Citations
“…PAX8/PPARG rearrangements occur in approximately 8% of FA, 10% of NIFTP, 1% of follicular variant PTC and 20–30% of FTC. EIF1AX mutation can be found in hyperplastic nodules, FA, NIFTP, FTC, PTC, PDC, ATC and Hürthle cell carcinomas . Cytogenetic changes occur in 50% of FA and 65% of FTC .…”
Section: Genetic Profiles and Molecular Diagnosis Of Thyroid Tumorsmentioning
confidence: 99%
“…Somatic genomic alterations in Hürthle cell carcinomas are different from those in PTC and FTC. Hürthle cell carcinomas have MADCAM1, EIF1AX, NRAS, DAXX, PT53 and NF1 mutations , but no BRAF mutations and a lower frequency of NRAS mutation than FTC . Somatic recurrent mitochondrial mutations occur in 71% of Hürthle cell carcinomas.…”
Section: Genetic Profiles and Molecular Diagnosis Of Thyroid Tumorsmentioning
confidence: 99%
See 3 more Smart Citations